Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Trichomonas vaginalis | set domain proteins, putative | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Brugia malayi | Pre-SET motif family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Onchocerca volvulus | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | replication protein A1, large subunit, putative | 0.0091 | 0.2443 | 1 |
Trichomonas vaginalis | replication factor A 1, rfa1, putative | 0.0189 | 0.6261 | 0.5052 |
Leishmania major | replication factor A, 51kDa subunit, putative | 0.0091 | 0.2443 | 0.5 |
Echinococcus granulosus | replication protein A 70 kDa DNA binding | 0.0189 | 0.6261 | 1 |
Trypanosoma brucei | Replication factor A protein 1 | 0.0091 | 0.2443 | 0.5 |
Loa Loa (eye worm) | replication factor A 73 kDa subunit | 0.0189 | 0.6261 | 0.7126 |
Brugia malayi | BRCA2 repeat family protein | 0.0038 | 0.0409 | 0.0103 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0036 | 0.0323 | 0.0086 |
Giardia lamblia | Hypothetical protein | 0.0028 | 0 | 0.5 |
Plasmodium falciparum | replication protein A1, large subunit | 0.0091 | 0.2443 | 0.5 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.8656 | 1 |
Brugia malayi | replication factor A 73 kDa subunit | 0.0189 | 0.6261 | 0.7126 |
Echinococcus multilocularis | replication protein A 70 kDa DNA binding | 0.0189 | 0.6261 | 1 |
Toxoplasma gondii | OB-fold nucleic acid binding domain-containing protein | 0.0048 | 0.077 | 0.211 |
Schistosoma mansoni | replication factor A 1 rfa1 | 0.0189 | 0.6261 | 1 |
Trichomonas vaginalis | replication factor A 1, rfa1, putative | 0.018 | 0.5899 | 0.4574 |
Entamoeba histolytica | replication factor A protein 1, putative | 0.0081 | 0.2081 | 0.5 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.8656 | 1 |
Loa Loa (eye worm) | BRCA2 repeat family protein | 0.0038 | 0.0409 | 0.0103 |
Onchocerca volvulus | Putative replication factor A 73 kDa subunit | 0.017 | 0.5491 | 0.534 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 1 | 1 |
Toxoplasma gondii | replication factor-a protein 1 (rpa1) subfamily protein | 0.0091 | 0.2443 | 1 |
Trypanosoma cruzi | Replication factor A protein 1 | 0.0091 | 0.2443 | 0.5 |
Trichomonas vaginalis | replication factor A 1, rfa1, putative | 0.0189 | 0.6261 | 0.5052 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 7.9433 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 31.5479 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.